Anti-Rho(D) Human Immunoglobulin

抗Rho(D)人免疫球蛋白（新疆德源生物）

Report date: 2026/01/07 09:46:15

Base Information

Drug NameAnti-Rho(D) Human Immunoglobulin
Drug Alias Name抗D人免疫球蛋白
ClassificationBiologics > Blood componentsBiologics > Protein drugs > Immunoglobulin
Mechanisms of ActionBlood group Rh(D) polypeptide inhibitors
TargetsBlood group Rh(D) polypeptide
Therapy Area/IndicationsErythroblastosis, Fetal
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusIND
Highest Status in ChinaIND
Originator CompaniesXinjiang Deyuan Biological Engineering Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesXinjiang Deyuan Biological Engineering Co Ltd
Inactive CompaniesN/A
Active IndicationsErythroblastosis, Fetal
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A